Haemonetics Corporation Financial Ratios — HAE Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Return on Common Equity (%)	17.26	9.7	8.44	3.95	-15.07	-8.65	16.34	25.63	63.52	66.92	24	50.55	38.25	46.99	30.77
Return on Assets (%)	7.67	3.27	2.36	1.13	-3.96	-2.05	3.68	4.38	6.02	5.15	2.36	6.08	5.69	7.22	4.02
Return on Capital (%)	17.07	6.84	5.22	2.56	- -	- -	8.71	12.08	17.57	- -	5.95	12.76	11.67	12.77	7.73
Return on Invested Capital (%)	9.02	4.7	3.66	1.84	- -	- -	4.14	6.12	12.39	- -	3.23	8.16	8.12	8.37	9.05
Gross Margin (%)	50.73	48	49.91	47.72	44.66	42.71	45.57	43.15	49.02	45.7	50.9	52.63	52.83	55.04	59.04
EBITDA Margin (%)	18.84	14.14	13.84	14.18	14.7	14.55	16.09	19.94	25.91	16.22	17.01	21.3	20.82	23.28	26.47
Operating Margin (%)	11.98	6.8	5.13	4.73	4.81	4.43	6.21	8.63	14.76	6.54	7.16	13.32	13.39	14.78	18.1
Incremental Operating Margin (%)	-41.99	-16.14	-26.86	18.22	-43.02	19.87	95.16	43.03	298.19	75.36	11.58	48.16	14	50	-150.07
Pretax Margin (%)	12.3	5.59	3.88	3.42	-5.88	-3.1	6.6	7.61	8.82	8.38	6.41	12.1	11.6	15.58	9.6
Profit Margin (%)	9.19	4.35	3.75	1.86	-6.12	-2.96	5.04	5.69	7.74	9.13	4.37	9.87	8.98	12.32	7.29
Net Income to Common Margin (%)	9.19	4.35	3.75	1.86	-6.12	-2.96	5.04	5.69	7.74	9.13	4.37	9.87	8.98	12.32	7.29
Effective Tax Rate (%)	25.27	22.24	3.44	45.78	- -	- -	23.58	25.28	12.19	- -	31.83	18.39	22.59	20.93	24
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	17.26	9.7	8.44	3.95	-15.07	-8.65	16.34	25.63	63.52	66.92	24	50.55	38.25	46.99	30.77

Credit (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Total Debt	4	480	438	428	408	315	254	350	442	715	774	766	808	1,225	1,225
ST Debt	1	23	46	22	43	61	194	28	84	25	214	12	10	304	5
LT Debt	3	457	392	406	365	254	59	322	358	691	559	754	798	921	1,220
Total Debt/EBITDA	0.03	3.81	3.37	3.31	3.05	2.44	1.74	1.81	1.72	5.07	4.58	3.08	2.96	3.87	3.47
Net Debt/EBITDA	-1.64	2.39	1.89	2.07	2.19	1.36	0.51	0.94	0.96	3.65	3.04	1.93	2.31	2.9	2.77
Total Debt/EBIT	0.04	7.91	9.08	9.94	9.33	8.02	4.52	4.19	3.03	12.56	10.87	4.92	4.61	6.09	5.07
Net Debt/EBIT	-2.58	4.96	5.09	6.21	6.7	4.47	1.31	2.16	1.68	9.05	7.23	3.09	3.59	4.56	4.06
EBITDA to Interest Expense	- -	19.29	11.89	13.77	14.11	15.93	32.13	19.47	15.81	8.39	9.86	17.02	20.93	32.5	12.3
EBITDA-CapEx/Interest Expense	- -	19.29	11.89	13.77	14.11	15.93	32.13	19.47	15.81	8.39	9.86	17.02	20.93	32.5	12.3
EBIT to Interest Expense	- -	9.28	4.41	4.59	4.62	4.84	12.41	8.43	9	3.38	4.16	10.64	13.47	20.64	8.41
Interest Expense	- -	7	11	9	9	8	5	10	16	17	17	15	13	10	29
Common Equity/Total Assets	44.04	27.27	28.65	28.33	24.01	23.45	21.62	12.7	6.24	8.71	10.91	13.11	16.44	14.39	11.68
Long-Term Debt/Equity (%)	0.39	59.41	46.79	49.19	50.52	34.29	7.9	48.28	60.9	94.39	74.65	92.19	83.08	112.23	153.15
Long-Term Debt/Capital (%)	0.71	52	44.98	47.88	50.3	41.92	11.4	62.97	68.65	79.03	57.29	73.96	68.24	58.4	81.07
Long-Term Debt/Total Assets (%)	0.32	31.26	25.89	27.36	27.63	20.47	4.8	25.3	28.22	37.95	30.08	38.98	36.33	37.59	50.9
Total Debt/Equity (%)	0.51	62.42	52.24	51.8	56.54	42.54	33.72	52.42	75.25	97.76	103.22	93.63	84.15	149.21	153.78
Total Debt/Capital (%)	0.93	54.63	50.22	50.41	56.3	52	48.68	68.38	84.83	81.86	79.22	75.12	69.12	77.64	81.4
Total Debt/Total Assets (%)	0.41	32.84	28.91	28.81	30.93	25.4	20.5	27.47	34.87	39.3	41.6	39.58	36.79	49.97	51.11
Net Debt to Equity	-30.72	39.13	29.27	32.35	40.59	23.67	9.77	27.07	41.76	70.43	68.6	58.85	65.52	111.84	122.96
Net Debt/Capital (%)	-127.75	43.02	36.11	38.84	48.05	37.61	21.56	52.75	63.93	75.61	71.7	65.49	63.54	72.25	77.78
EBITDA	137	126	130	129	134	129	145	193	256	141	169	249	273	317	353
EBITDA-CapEx	84	126	130	129	134	129	145	193	256	141	169	249	273	317	353
Operating Income (Loss)	87	61	48	43	44	39	56	84	146	57	71	156	175	201	241

Liquidity (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Cash Ratio	1.75	0.99	0.89	0.85	0.62	0.66	0.47	0.72	0.5	0.76	0.59	1.13	0.6	0.53	0.87
Current Ratio	4.03	3.31	2.87	2.96	2.63	2.42	1.35	2.44	2.2	2.74	1.71	3.06	2.56	1.62	2.95
Quick Ratio	2.79	1.94	1.65	1.62	1.47	1.38	0.86	1.5	1.1	1.26	0.95	1.84	1.28	0.88	1.64
CFO/Avg Current Liab	0.96	0.55	0.7	0.63	0.65	0.81	0.74	0.51	0.62	0.41	0.5	0.79	0.66	0.41	0.68
Common Equity/Total Assets	44.04	27.27	28.65	28.33	24.01	23.45	21.62	12.7	6.24	8.71	10.91	13.11	16.44	14.39	11.68
Long-Term Debt/Equity (%)	0.39	59.41	46.79	49.19	50.52	34.29	7.9	48.28	60.9	94.39	74.65	92.19	83.08	112.23	153.15
Long-Term Debt/Capital (%)	0.71	52	44.98	47.88	50.3	41.92	11.4	62.97	68.65	79.03	57.29	73.96	68.24	58.4	81.07
Long-Term Debt/Total Assets (%)	0.32	31.26	25.89	27.36	27.63	20.47	4.8	25.3	28.22	37.95	30.08	38.98	36.33	37.59	50.9
Total Debt/Equity (%)	0.51	62.42	52.24	51.8	56.54	42.54	33.72	52.42	75.25	97.76	103.22	93.63	84.15	149.21	153.78
Total Debt/Capital (%)	0.93	54.63	50.22	50.41	56.3	52	48.68	68.38	84.83	81.86	79.22	75.12	69.12	77.64	81.4
Total Debt/Total Assets (%)	0.41	32.84	28.91	28.81	30.93	25.4	20.5	27.47	34.87	39.3	41.6	39.58	36.79	49.97	51.11
CFO/Total Liabilities	64.6	12.28	20.63	19.29	20.39	32.01	45.44	26.25	23.27	10	15.51	24.45	14.71	11.15	18.33
CFO/CapEx	2.17	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	8.87	4.33	3.91	4.41	3.98	4.61	6.65	6.46	6.6	4.93	3.49	4.49	4.51	3.3	3.46

Working Capital (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Accounts Receivable Turnover	5.54	5.84	5.61	5.87	6	5.72	5.95	5.76	5.64	5.95	6.92	6.9	6.79	6.65	6.36
Days Sales Outstanding	65.85	62.52	65.09	62.23	60.83	63.8	61.36	63.42	64.66	61.38	52.72	52.86	53.77	54.88	57.39
Inventory Turnover	3.56	3.08	2.47	2.33	2.53	2.79	2.91	3.1	2.17	1.59	1.58	2	2.14	1.79	1.63
Days Inventory Outstanding	102.57	118.4	148.07	156.73	144.47	130.85	125.27	117.83	168.25	228.94	230.38	182.12	170.4	203.52	224.27
Accounts Payable Turnover	12.28	12.44	9.36	9.6	10.87	12.04	9.69	9.84	10.17	10.39	8.43	8.5	9.84	9.4	8.26
Accounts Payable Turnover Days	29.73	29.35	39.01	38.03	33.58	30.32	37.67	37.1	35.91	35.12	43.29	42.93	37.1	38.82	44.18
Cash Conversion Cycle	138.7	151.57	174.15	180.92	171.72	164.33	148.96	144.16	197.01	255.2	239.81	192.05	187.08	219.58	237.48
Inventory to Cash Days	-36.72	-55.88	-82.98	-94.5	-83.64	-67.05	-63.91	-54.41	-103.59	-167.56	-177.66	-129.25	-116.63	-148.64	-166.88
Inventories	117	184	198	211	187	177	161	194	270	323	293	259	317	365	306
Raw Materials	41	71	73	72	62	52	53	69	77	75	78	115	134	129	115
Work In Process	5	8	7	12	13	10	11	13	11	23	17	13	15	15	12
Finished Goods	71	105	118	127	112	114	97	112	182	225	198	132	168	222	180
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Market Capitalization	1,767	2,139	1,682	2,315	1,781	2,090	3,860	4,508	5,052	5,627	3,227	4,202	4,328	3,198	2,659
- Cash & Cash Equivalents	229	179	192	161	115	140	180	169	137	192	259	284	179	307	245
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	480	438	428	408	315	254	350	442	715	774	766	808	1,225	1,225
Enterprise Value	1,542	2,440	1,927	2,582	2,074	2,265	3,933	4,689	5,356	6,150	3,741	4,684	4,957	4,116	3,638
Total Capital	405	879	872	849	725	605	521	512	521	874	976	1,020	1,169	1,577	1,504
Total Debt/Capital (%)	0.93	54.63	50.22	50.41	56.3	52	48.68	68.38	84.83	81.86	79.22	75.12	69.12	77.64	81.4
Total Debt / EV	- -	0.2	0.23	0.17	0.2	0.14	0.06	0.07	0.08	0.12	0.21	0.16	0.16	0.3	0.34
EV/Sales	2.12	2.74	2.05	2.84	2.28	2.56	4.35	4.85	5.42	7.07	3.77	4.01	3.79	3.03	2.73
EV/EBITDA	11.25	19.34	14.83	20	15.52	17.57	27.05	24.3	20.91	43.55	22.15	18.81	18.19	13	10.3
EV/EBIT	17.69	40.21	39.99	59.96	47.43	57.77	70.04	56.12	36.72	108.02	52.59	30.09	28.28	20.46	15.07
EV/Cash Flow to Firm	13.37	27.07	12.84	19.52	15.74	13.53	17.57	28.13	31.06	48.37	20.34	16.43	25.84	21.73	11.55
EV/Free Cash Flow to Firm	9.15	27.07	12.84	19.52	15.74	13.53	17.57	28.13	31.06	48.37	20.34	16.43	25.84	21.73	11.55
Diluted Market Cap	1,797	2,177	1,707	2,340	1,781	2,090	3,914	4,631	5,164	5,694	3,247	4,255	4,387	3,224	2,669
Diluted Enterprise Value	1,572	2,478	1,952	2,607	2,074	2,265	3,988	4,812	5,468	6,217	3,761	4,736	5,016	4,142	3,648
EV per Share	30.4	47.52	37.34	50.11	40.73	43.97	74.55	90.99	105.67	121.33	73.29	92.23	97.75	81.79	77.11
TTM Sales	728	892	939	910	909	886	904	968	988	870	993	1,169	1,309	1,361	1,334
TTM EBITDA	137	126	130	129	134	129	145	193	256	141	169	249	273	317	353
TTM Operating Income	87	61	48	43	44	39	56	84	146	57	71	156	175	201	241
TTM Cash Flow to Firm	115	90	150	132	132	167	224	167	172	127	184	285	192	189	315
TTM Free Cash Flow to Firm	169	90	150	132	132	167	224	167	172	127	184	285	192	189	315

Multiples (USD)

API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	03/31/2012	03/31/2013	03/31/2014	03/31/2015	03/31/2016	03/31/2017	03/31/2018	03/31/2019	03/31/2020	03/31/2021	03/31/2022	03/31/2023	03/31/2024	03/31/2025	03/31/2026

Price/Free Cash Flow	10.67	25.59	12.23	18.4	14.61	13.09	17.76	29.08	32.64	52.33	18.85	15.58	24.14	17.74	9.1
EV/EBIT	17.69	40.21	39.99	59.96	47.43	57.77	70.04	56.12	36.72	108.02	52.59	30.09	28.28	20.46	15.07
Enterprise Value	1,542	2,440	1,927	2,582	2,074	2,265	3,933	4,689	5,356	6,150	3,741	4,684	4,957	4,116	3,638
Low Price	27.5	32.69	31.8	29.86	29.2	25.98	38.47	70.86	63.41	74.48	43.5	48.67	70.74	58.8	47.32
EV/Sales	2.12	2.74	2.05	2.84	2.28	2.56	4.35	4.85	5.42	7.07	3.77	4.01	3.79	3.03	2.73
EV/EBITDA	11.25	19.34	14.83	20	15.52	17.57	27.05	24.3	20.91	43.55	22.15	18.81	18.19	13	10.3
Price/Earnings	26.42	55.13	47.85	137	- -	- -	84.69	81.94	66.02	70.81	74.4	36.41	36.81	19.07	27.33
Price/Earnings Average	24.07	51.01	59.44	112.34	-33.11	-69.22	58.84	89.9	75.38	66.81	73.34	32.17	36.55	23.84	31.56
Price/Earnings High	26.86	58.81	67.4	138.54	-41.48	-81.7	87.34	110.11	92.98	90.64	141.08	40.22	41.09	29.41	42.34
Price/Earnings Low	20.85	43.26	46.69	91.07	-26.75	-50.96	44.53	66.37	42	47.51	51.19	21.42	30.51	17.65	22.94
Price/Book Value	4.4	5.37	3.88	5.5	5.62	7.2	14.43	27.84	63.94	35.5	15.91	16.57	11.99	9.07	9.5
Price/Book Value Average	4.01	4.96	4.82	4.51	5.81	6.26	10.03	30.55	73	33.5	15.68	14.63	11.9	11.33	10.98
Price/Book Value High	4.48	5.72	5.46	5.56	7.28	7.39	14.88	37.41	90.05	45.45	30.16	18.3	13.38	13.98	14.72
Price/Book Value Low	3.48	4.21	3.78	3.66	4.69	4.61	7.59	22.55	40.68	23.82	10.94	9.74	9.94	8.39	7.98
Price/Tangible Book Value	3.39	12.27	7.31	9.36	7.14	5.95	10.04	13.69	20.76	-56.12	-114.75	55.3	-385.03	-13.37	-8.64
Price/Tangible Book Value Average	3.09	11.35	9.08	7.68	7.38	5.18	6.98	15.02	23.7	-52.96	-113.12	48.85	-382.28	-16.71	-9.98
Price/Tangible Book Value High	3.45	13.09	10.3	9.47	9.25	6.11	10.35	18.39	29.24	-71.85	-217.59	61.07	-429.74	-20.62	-13.39
Price/Tangible Book Value Low	2.68	9.63	7.14	6.22	5.96	3.81	5.28	11.09	13.21	-37.66	-78.96	32.52	-319.12	-12.37	-7.26
Price/Sales	2.43	2.4	1.79	2.54	1.96	2.36	4.27	4.66	5.11	6.46	3.25	3.6	3.31	2.35	1.99
Price/Sales Average	2.21	2.22	2.23	2.09	2.03	2.05	2.97	5.11	5.84	6.1	3.2	3.18	3.28	2.94	2.3
Price/Sales High	2.47	2.56	2.52	2.57	2.54	2.42	4.4	6.26	7.2	8.28	6.16	3.97	3.69	3.62	3.09
Price/Sales Low	1.92	1.88	1.75	1.69	1.64	1.51	2.25	3.77	3.25	4.34	2.24	2.11	2.74	2.17	1.67
Price/Cash Flow	15.33	25.15	12.06	18.2	14.61	13.09	17.52	28.3	31.93	51.72	18.73	15.39	23.81	17.6	9.07
Price/Cash Flow Average	13.96	23.27	14.97	14.93	15.1	11.38	12.17	31.05	36.46	48.8	18.47	13.59	23.64	22	10.47
Price/Cash Flow High	15.58	26.82	16.98	18.41	18.92	13.43	18.06	38.03	44.97	66.2	35.52	17	26.58	27.13	14.05
Price/Cash Flow Low	12.09	19.73	11.76	12.1	12.2	8.38	9.21	22.93	20.32	34.7	12.89	9.05	19.74	16.29	7.61
Price/Free Cash Flow Average	9.71	23.68	15.2	15.09	15.1	11.38	12.34	31.9	37.27	49.38	18.58	13.76	23.96	22.17	10.51
Price/Free Cash Flow High	10.84	27.3	17.23	18.6	18.92	13.43	18.32	39.07	45.97	66.99	35.74	17.21	26.94	27.35	14.1
Price/Free Cash Flow Low	8.42	20.08	11.94	12.23	12.2	8.38	9.34	23.55	20.77	35.11	12.97	9.17	20	16.41	7.64
EV/Sales Average	1.9	2.56	2.49	2.38	2.35	2.25	3.05	5.3	6.14	6.7	3.72	3.59	3.76	3.61	3.04
EV/Sales High	2.16	2.9	2.79	2.86	2.86	2.62	4.48	6.45	7.51	8.88	6.68	4.38	4.17	4.3	3.82
EV/Sales Low	1.61	2.22	2.01	1.98	1.96	1.71	2.33	3.96	3.56	4.94	2.75	2.53	3.22	2.85	2.41
EV/EBITDA Average	10.1	18.07	17.97	16.77	15.96	15.46	18.95	26.57	23.71	41.3	21.88	16.84	18.08	15.52	11.47
EV/EBITDA High	11.46	20.47	20.12	20.2	19.44	18	27.88	32.33	28.97	54.71	39.28	20.58	20.03	18.46	14.44
EV/EBITDA Low	8.53	15.69	14.52	13.99	13.32	11.74	14.46	19.86	13.74	30.44	16.19	11.86	15.47	12.24	9.1
EV/EBIT Average	15.88	37.58	48.44	50.29	48.79	50.83	49.06	61.37	41.63	102.44	51.94	26.94	28.1	24.43	16.78
EV/EBIT High	18.02	42.56	54.25	60.57	59.42	59.19	72.19	74.68	50.87	135.7	93.24	32.91	31.14	29.07	21.12
EV/EBIT Low	13.42	32.62	39.15	41.94	40.7	38.6	37.45	45.87	24.12	75.49	38.44	18.97	24.05	19.27	13.3
Last Price	34.84	41.66	32.59	44.92	34.98	40.57	73.16	87.48	99.66	111.01	63.22	82.75	85.35	63.55	56.36
High Price	35.41	44.44	45.9	45.42	45.28	41.65	75.45	117.56	140.36	142.11	119.88	91.39	95.26	97.97	87.32
Enterprise Value Average	1,385	2,280	2,334	2,166	2,133	1,993	2,755	5,127	6,073	5,832	3,695	4,193	4,926	4,915	4,050
Enterprise Value High	1,571	2,583	2,614	2,608	2,598	2,321	4,054	6,239	7,420	7,726	6,634	5,122	5,459	5,849	5,099
Enterprise Value Low	1,170	1,980	1,886	1,806	1,779	1,514	2,103	3,832	3,519	4,298	2,735	2,953	4,216	3,877	3,212

Shares Outstanding	51	51	52	52	51	52	52	51	50	51	51	50	51	48	45
Diluted Weighted Avg Shares	52	52	52	52	51	52	54	53	52	51	51	51	51	51	47
Basic Weighted Avg Shares	51	51	52	52	51	52	53	52	51	51	51	51	51	50	47
Revenue per Share	14.35	17.37	18.18	17.67	17.85	17.2	17.13	18.78	19.5	17.17	19.46	23.01	25.82	27.04	28.28
EBITDA per Share	2.7	2.46	2.52	2.51	2.62	2.5	2.76	3.74	5.05	2.79	3.31	4.9	5.37	6.29	7.48
Operating Income per Share	1.72	1.18	0.93	0.84	0.86	0.76	1.06	1.62	2.88	1.12	1.39	3.07	3.46	4	5.12
Basic EPS, GAAP	1.32	0.76	0.68	0.33	-1.09	-0.51	0.86	1.07	1.51	1.57	0.85	2.27	2.32	3.33	2.06
Basic EPS from Cont Ops	1.32	0.76	0.68	0.33	-1.09	-0.51	0.86	1.07	1.51	1.57	0.85	2.27	2.32	3.33	2.06
Diluted EPS, GAAP	1.3	0.74	0.67	0.32	-1.09	-0.51	0.85	1.04	1.48	1.55	0.84	2.24	2.29	3.31	2.05
Diluted EPS from Cont Ops	1.3	0.74	0.67	0.32	-1.09	-0.51	0.85	1.04	1.48	1.55	0.84	2.24	2.29	3.31	2.05
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	2.27	1.66	2.7	2.47	2.39	3.1	4.18	3.09	3.12	2.15	3.37	5.38	3.58	3.61	6.22
Free Cash Flow per Basic Share	1.22	1.66	2.7	2.47	2.39	3.1	4.18	3.09	3.12	2.15	3.37	5.38	3.58	3.61	6.22
Cash & Equivalents per Share	4.51	3.49	3.73	3.12	2.26	2.71	3.42	3.29	2.71	3.79	5.08	5.6	3.53	6.1	5.2
Book Value per Share	7.91	7.76	8.41	8.17	6.22	5.64	5.07	3.14	1.56	3.13	3.97	5	7.12	7.01	5.93
Tangible Book Value per Share	10.27	3.39	4.46	4.8	4.9	6.82	7.29	6.39	4.8	-1.98	-0.55	1.5	-0.22	-4.75	-6.52

Haemonetics Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)